Clinical implications of AGBL2 expression and its inhibitor latexin in breast cancer

BACKGROUND: We investigated the expression status of AGBL2 and its inhibitor latexin in breast cancer stem cells and its clinical implications in order to lay a foundation for managing breast cancer. METHODS: CD44+/CD24- tumor cells (CSC) from clinical specimens were sorted using flow cytometry. AGB...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Hao, Ren, Yuan, Pang, Deyan, Liu, Caigang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4069086/
https://www.ncbi.nlm.nih.gov/pubmed/24884516
http://dx.doi.org/10.1186/1477-7819-12-142

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4069086/
https://www.ncbi.nlm.nih.gov/pubmed/24884516
http://dx.doi.org/10.1186/1477-7819-12-142

Ejemplares similares